000 | 01681 a2200469 4500 | ||
---|---|---|---|
005 | 20250517003747.0 | ||
264 | 0 | _c20150316 | |
008 | 201503s 0 0 hun d | ||
022 | _a0030-6002 | ||
024 | 7 |
_a10.1556/OH.2014.30046 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJanovszky, Ágnes | |
245 | 0 | 0 |
_a[Current approaches for early detection and treatment of medication-related osteonecrosis of jaw]. _h[electronic resource] |
260 |
_bOrvosi hetilap _cDec 2014 |
||
300 |
_a1960-6 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 |
_aAnalgesics _xadministration & dosage |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xdiagnosis |
650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
650 | 0 | 4 |
_aBone Neoplasms _xcomplications |
650 | 0 | 4 | _aDebridement |
650 | 0 | 4 | _aEarly Diagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLaser Therapy |
650 | 0 | 4 | _aLow-Level Light Therapy |
650 | 0 | 4 |
_aOzone _xtherapeutic use |
650 | 0 | 4 |
_aPentoxifylline _xtherapeutic use |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSaliva |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aTeriparatide _xtherapeutic use |
650 | 0 | 4 |
_aalpha-Tocopherol _xtherapeutic use |
700 | 1 | _aVereb, Tamás | |
700 | 1 | _aSzabó, Andrea | |
700 | 1 | _aPiffkó, József | |
773 | 0 |
_tOrvosi hetilap _gvol. 155 _gno. 49 _gp. 1960-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1556/OH.2014.30046 _zAvailable from publisher's website |
999 |
_c24389689 _d24389689 |